Taking RNAi From Interesting Science to Impactful New Treatments
May 14, 2024
May 14, 2024
CAMBRIDGE, Massachusetts, May 14 (TNSres) -- The Massachusetts Institute of Technology issued the following news:
* * *
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.
* * *
By Zach Winn, MIT News
There are many hurdles to clear before a research discovery becomes a life-changing treatment for patients. That's especially tru . . .
* * *
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.
* * *
By Zach Winn, MIT News
There are many hurdles to clear before a research discovery becomes a life-changing treatment for patients. That's especially tru . . .